Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Jacob Liawatidewi is recorded as Board Member at Amphastar Pharmaceuticals, Inc. (AMPH). Amphastar Pharmaceuticals, Inc. reported in an 8-K filed August 9, 2022 that Jacob Liawatidewi was appointed Class I director, effective August 4, 2022. Jacob Liawatidewi has spoken on 1 investor event across 1 company, most recently for Amphastar Pharmaceuticals, Inc. on June 3, 2026.
“approved an increase to the authorized number of directors permitted to serve on the Board from eight (8) to ten (10) directors and appointed each of William J. Peters, the Company's Chief Financial Officer, Executive Vice President of Finance, and Treasurer, and Jacob Liawatidewi, the Company's Executive Vice President of Corporate Administration Center, and Sales and Marketing (together with Mr. Peters, the "New Directors"), to serve as Class I directors, to hold office until the Company's 2023 annual meeting of stockholders and until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation or removal, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2022-08-04–present
Proxy statement
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
Board Member
2022-08-04–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
